Increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and increasing number of drug development initiatives.
The global Creatinine Measurement market size is projected to reach USD 700.8 million by 2027 from USD 377.2 million in 2018, at a CAGR of 8.4%.
F. Hoffmann-la Roche Ltd (Switzerland), Abbott Laboratories (US), Danaher Corporation (US), Thermo Fisher Scientific (US), Siemens Healthineers (Germany), Randox Laboratories (UK), Pointe Scientific (US), Sentinel Ch. Spa. (Italy), Diasys Diagnostic Systems GmbH (Germany), Dialab GmbH (Vienna), Diazyme Laboratories (US), Wako Pure Chemical Industries, Ltd. (Japan), Ortho Clinical Diagnostics (US), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China) are some key players in this market. These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, acquisitions, and expansions.
For More Details, Download a PDF Brochure:-
“F. Hoffmann-La Roche was the leading player in the creatinine measurement market in 2017”
The dominant share of this company is attributed to its exhaustive product portfolio and strong global reach, especially in the emerging economies. For maintaining its market position, the company mainly focuses on investments toward R&D activities to fuel innovation. The company invested USD 10.18 billion (19.5% of total sales) on R&D activities in 2017. With its strong R&D capabilities and state-of-the-art asset quality, the company is also expected to grow during the forecast period.
“Danaher is one of the major players in the creatinine measurement market”
The company has a strong brand name in high-growth geographies and a growing presence in the emerging markets. The company has a strong focus on research and development and spent USD 1,128.8 million on R&D in 2017. The company has a vast geographic presence in over 60 countries. Beckman Coulter (Danaher’s parent company) provides customer sales support in remote locations through its PROService Remote Diagnostics.
We can help with your specific research requirement for this market. Please share your specific interest to help us serve you better, Request Sample Pages:-